(Q37873869)

24 August 2017

1 reference

title

Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'. (English)

1 reference

24 August 2017

Rudy J Castellani

1

1 reference

24 August 2017

Mark A Smith

series ordinal

2

1 reference

24 August 2017

publication date

1 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

224

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

147-152

1 reference

Alzheimer disease pathology as a host response

24 August 2017

cites work

1 reference

Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta

21 January 2018

1 reference

Can Alzheimer disease be prevented by amyloid-beta immunotherapy?

21 January 2018

1 reference

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

21 January 2018

1 reference

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

The significance of neuroinflammation in understanding Alzheimer's disease.

21 January 2018

1 reference

Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease

21 January 2018

1 reference

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

21 January 2018

1 reference

Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease

21 January 2018

1 reference

Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms

21 January 2018

1 reference

Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40.

21 January 2018

1 reference

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

21 January 2018

1 reference

Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

21 January 2018

1 reference

Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease

21 January 2018

1 reference

Identification of normal and pathological aging in prospectively studied nondemented elderly humans

21 January 2018

1 reference

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

21 January 2018

1 reference

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

21 January 2018

1 reference

Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.

21 January 2018

1 reference

Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.

21 January 2018

1 reference

A beta oligomers - a decade of discovery

21 January 2018

1 reference

New V272A presenilin 1 mutation with very early onset subcortical dementia and parkinsonism.

21 January 2018

1 reference

A presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis

21 January 2018

1 reference

Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry.

21 January 2018

1 reference

Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study.

21 January 2018

1 reference

Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship

21 January 2018

1 reference

The synaptic Abeta hypothesis of Alzheimer disease

21 January 2018

1 reference

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

21 January 2018

1 reference

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

Operationalization of mild cognitive impairment: a graphical approach.

21 January 2018

1 reference

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease

21 January 2018

1 reference

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s

21 January 2018

1 reference

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

Working memory in early Alzheimer's disease: a neuropsychological review.

21 January 2018

1 reference

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

Mild cognitive impairment in the older population: Who is missed and does it matter?

21 January 2018

1 reference

Conversion from subtypes of mild cognitive impairment to Alzheimer dementia

21 January 2018

1 reference

Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts

21 January 2018

1 reference

Vascular risk factors, incidence of MCI, and rates of progression to dementia

21 January 2018

1 reference

Conversion to dementia from mild cognitive disorder: the Cache County Study.

21 January 2018

1 reference

Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population

21 January 2018

1 reference

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

Apolipoprotein E allele 4 is not a sufficient or a necessary predictor of the development of Mild Cognitive Impairment.

21 January 2018

1 reference

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

21 January 2018

1 reference

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

21 January 2018

1 reference

Safety and efficacy of galantamine in subjects with mild cognitive impairment

21 January 2018

1 reference

Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial

21 January 2018

1 reference

Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.2885

1 reference

24 August 2017

1 reference